Regression of a venous malformation during angiotensin-converting enzyme inhibitor treatment for hypertension.
Sigurd Berger, Therese Halvorsen Bjark, Karsten Midtvedt...
https://pubmed.ncbi.nlm.nih.gov/36262918/Actively Recruiting
Phase 2
Age: 18Years - 70Years
All Genders
ID06788314
Phase 2 Study of Enalapril for Adults Aged 18 to 70 With Painful Venous Malformations to Reduce Pain and Improve Quality of Life
Led by Oslo University Hospital · Updated on 2025-04-02
12
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to explore the potential use of enalapril to treat painful venous malformations, which are congenital vascular defects that can cause disfigurement and pain, affecting patients quality of life. The study investigates whether enalapril can reduce the pain and volume of these malformations and improve quality of life in affected patients aged 18 to 70. The trial is a phase 2, single-center, single-arm pilot study led by Oslo University Hospital.
CONDITIONS
Brief Title
A Study of Enalapril in Treatment of Venous Malformations
Research Team
C
Christina Bjerring Opheim, MD and PhD student
N
Nina Haagenrud Schultz, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here